[1]
J. Liu, Y. Ge, L. Dworkin, and R. Gong, “Activation of podocyte-specific MC5R signaling by melanocortin therapy protects against THSD7A-associated membranous nephropathy”, Translation, vol. 13, no. S3, Jun. 2025.